TABLE 1.
Demographics and baseline characteristics
| Total (n = 8) | |
|---|---|
| Age, years | 58 (36–78) |
| Sex | |
| Female | 4 |
| Weight at baseline, kg | 79.6 (54.0–95.5) |
| Body mass index, kg/m2 | 24.5 (20.2–31.0) |
| Race, White | 8 |
| PS volume, ml/day | 3315 (425–6616) |
| PS energy, kJ/day | 4419 (0–10,317) |
| Days of PS per week | 6.5 (3–7) |
| Urine volume output, ml/day | 2395 (392–3575) |
| Dietary fluid intake, ml/day | 2605 (1300–5475) |
| Urinary sodium excretion, mmol/day | 38 (4–265) |
| Plasma citrulline levels, μmol/L | 4.2 (1.7–17.9) |
| Cause of resection | |
| Crohn's disease | 2 |
| Mesenteric vascular disease | 3 |
| Surgical complications to ulcerative colitis | 1 |
| Surgical complications | 2 |
| Disease characteristics | |
| Small bowel length, cm | 100 (30–300) |
| Jejunostomy | 6 |
| Ileostomy | 2 |
| Colon in continuity | 0 |
| Concomitant medication | |
| Proton‐pump inhibitor | 7 |
| Opioids or opioid agonists | 4 |
| Loperamide | 3 |
Note: Data represent median (range) or number of patients. PS is scheduled PS at trial entry based on weekly average.
Abbreviation: PS, parenteral support.